SGLT-2 inhibitor use not linked to increased risk for UTI events

(HealthDay)—Initiation of therapy with sodium-glucose cotransporter-2 (SGLT-2) inhibitors for type 2 diabetes mellitus is not associated with an increased risk for urinary tract infection (UTI) events compared with initiation of other second-line antidiabetic medications, according to a study published online July 30 in the Annals of Internal Medicine.

source https://www.lifetechnology.com/blogs/life-technology-news-blog/sglt-2-inhibitor-use-not-linked-to-increased-risk-for-uti-events